share_log

Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights

アナリストによる見解を通じてパシラバイオサイエンシズを探る:レイヤーを剥がす

Benzinga ·  07/02 15:01

Analysts' ratings for Pacira BioSciences (NASDAQ:PCRX) over the last quarter vary from bullish to bearish, as provided by 6 analysts.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings51000
Last 30D20000
1M Ago00000
2M Ago21000
3M Ago10000

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $47.17, along with a high estimate of $57.00 and a low estimate of $38.00. Experiencing a 2.54% decline, the current average is now lower than the previous average price target of $48.40.

price target chart

Interpreting Analyst Ratings: A Closer Look

A clear picture of Pacira...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする